![](/img/cover-not-exists.png)
LBP-16-Phase II trial to evaluate immunogenicity and safety of a new adjuvanted HBAI20 Hepatitis B vaccine in non-responders: BE RESPONDER.
Koc, Özgür, Smedt, Philippe de, Robaeys, Geert, Damme, Pierre Van, Almeida, Jorge, Falkenberg, Frank, Savelkoul, Paul H.M., Lashof, Astrid OudeVolume:
70
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0618-8278(19)30262-2
Date:
April, 2019
File:
PDF, 58 KB
english, 2019